Exelixis Inc. (EXEL)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
61 - 70
Next >>

Why These 5 Stocks Are Making Moves Higher Today

Wall Street has recorded moderate gains on the first day of March, with crude prices being the main catalyst for the stock exchanges. Meanwhile, there are several stocks gaining today, some of which...

Keep Reading →

March 1st, 2016 - Market Movers News

What Do Hedge Funds Think of Exelixis, Inc. (EXEL)?

Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this...

Keep Reading →

November 28th, 2015 - Hedge Funds News

Did Hedge Funds Sell Out Of Exelixis, Inc. (EXEL) Too Soon? Shares Jump On Regulatory Approval of Cobimetinib

The shares of Exelixis, Inc. (NASDAQ:EXEL) have jumped by 3.01% in today's trading session, as the company announced the first regulatory approval for Cobimetinib.

Keep Reading →

August 27th, 2015 - Hedge Funds News

Exelixis, Inc. (EXEL) Soars Following Cancer Drug Trial Data, But Competition Looms

Shares of Exelixis, Inc.

Keep Reading →

July 20th, 2015 - Hedge Funds Market Movers News

An Excellent Investment in the Biotech Space?

According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease in 2013. Limited treatment...

Keep Reading →

September 23rd, 2013 - News

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.

Keep Reading →

September 17th, 2013 - News

New York Community Bancorp, Inc. (NYCB), Exelixis, Inc. (EXEL): Here's What This $53 Billion Hedge Fund Company Has Been Buying

The biggest new positions are call options on Microsoft and puts on Tesla Motors. Its biggest new holdings are Gilead Sciences and Scripps Networks Interactive.

Keep Reading →

September 10th, 2013 - News

Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)

If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.

Keep Reading →

September 4th, 2013 - News

Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)

In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets. Two of the most under-the-radar are hedge fund and insider trading activity.

Keep Reading →

September 3rd, 2013 - News

Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?

To the average investor, there are dozens of indicators market participants can use to analyze their holdings. A pair of the most under-the-radar are hedge fund and insider trading movement.

Keep Reading →

August 30th, 2013 - News